Development and Validation of the Dystonia-Pain Classification System: A Multicenter Study.
chronic pain
dystonia
nonmotor symptoms
pain
pain classification
Journal
Movement disorders : official journal of the Movement Disorder Society
ISSN: 1531-8257
Titre abrégé: Mov Disord
Pays: United States
ID NLM: 8610688
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
revised:
04
04
2023
received:
22
02
2023
accepted:
10
04
2023
medline:
31
7
2023
pubmed:
20
5
2023
entrez:
20
5
2023
Statut:
ppublish
Résumé
Dystonia is associated with disabling nonmotor symptoms like chronic pain (CP), which is prevalent in dystonia and significantly impacts the quality of life (QoL). There is no validated tool for assessing CP in dystonia, which substantially hampers pain management. The aim was to develop a CP classification and scoring system for dystonia. A multidisciplinary group was established to develop the Dystonia-Pain Classification System (Dystonia-PCS). The classification of CP as related or unrelated to dystonia was followed by the assessment of pain severity score, encompassing pain intensity, frequency, and impact on daily living. Then, consecutive patients with inherited/idiopathic dystonia of different spatial distribution were recruited in a cross-sectional multicenter validation study. Dystonia-PCS was compared to validated pain, mood, QoL, and dystonia scales (Brief Pain Inventory, Douleur Neuropathique-4 questionnaire, European QoL-5 Dimensions-3 Level Version, and Burke-Fahn-Marsden Dystonia Rating Scale). CP was present in 81 of 123 recruited patients, being directly related to dystonia in 82.7%, aggravated by dystonia in 8.8%, and nonrelated to dystonia in 7.5%. Dystonia-PCS had excellent intra-rater (Intraclass Correlation Coefficient - ICC: 0.941) and inter-rater (ICC: 0.867) reliability. In addition, pain severity score correlated with European QoL-5 Dimensions-3 Level Version's pain subscore (r = 0.635, P < 0.001) and the Brief Pain Inventory's severity and interference scores (r = 0.553, P < 0.001 and r = 0.609, P < 0.001, respectively). Dystonia-PCS is a reliable tool to categorize and quantify CP impact in dystonia and will help improve clinical trial design and management of CP in patients affected by this disorder. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Sections du résumé
BACKGROUND
Dystonia is associated with disabling nonmotor symptoms like chronic pain (CP), which is prevalent in dystonia and significantly impacts the quality of life (QoL). There is no validated tool for assessing CP in dystonia, which substantially hampers pain management.
OBJECTIVE
The aim was to develop a CP classification and scoring system for dystonia.
METHODS
A multidisciplinary group was established to develop the Dystonia-Pain Classification System (Dystonia-PCS). The classification of CP as related or unrelated to dystonia was followed by the assessment of pain severity score, encompassing pain intensity, frequency, and impact on daily living. Then, consecutive patients with inherited/idiopathic dystonia of different spatial distribution were recruited in a cross-sectional multicenter validation study. Dystonia-PCS was compared to validated pain, mood, QoL, and dystonia scales (Brief Pain Inventory, Douleur Neuropathique-4 questionnaire, European QoL-5 Dimensions-3 Level Version, and Burke-Fahn-Marsden Dystonia Rating Scale).
RESULTS
CP was present in 81 of 123 recruited patients, being directly related to dystonia in 82.7%, aggravated by dystonia in 8.8%, and nonrelated to dystonia in 7.5%. Dystonia-PCS had excellent intra-rater (Intraclass Correlation Coefficient - ICC: 0.941) and inter-rater (ICC: 0.867) reliability. In addition, pain severity score correlated with European QoL-5 Dimensions-3 Level Version's pain subscore (r = 0.635, P < 0.001) and the Brief Pain Inventory's severity and interference scores (r = 0.553, P < 0.001 and r = 0.609, P < 0.001, respectively).
CONCLUSIONS
Dystonia-PCS is a reliable tool to categorize and quantify CP impact in dystonia and will help improve clinical trial design and management of CP in patients affected by this disorder. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Types de publication
Multicenter Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1163-1174Informations de copyright
© 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Références
Albanese A, Bhatia K, Bressman SB, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord 2013;28(7):863-873.
Balint B, Mencacci NE, Valente EM, et al. Dystonia. Nat Rev Dis Primers 2018;4(1):25.
Eggink H, Coenen MA, de Jong R, et al. Motor and non-motor determinants of health-related quality of life in young dystonia patients. Parkinsonism Relat Disord 2019;58:50-55.
Eggink H, Szlufik S, Coenen MA, van Egmond ME, Moro E, Tijssen MAJ. Non-motor effects of deep brain stimulation in dystonia: a systematic review. Parkinsonism Relat Disord 2018;55:26-44.
Kuyper DJ, Parra V, Aerts S, Okun MS, Kluger BM. Nonmotor manifestations of dystonia: a systematic review. Mov Disord 2011;26(7):1206-1217.
Treede RD, Rief W, Barke A, et al. A classification of chronic pain for ICD-11. Pain 2015;156(6):1003-1007.
Dahlhamer J, Lucas J, Zelaya C, et al. Prevalence of chronic pain and high-impact chronic pain among adults-United States, 2016. MMWR Morb Mortal Wkly Rep 2018;67(36):1001-1006.
Leao Ferreira KA, Bastos TR, Andrade DC, et al. Prevalence of chronic pain in a metropolitan area of a developing country: a population-based study. Arq Neuropsiquiatr 2016;74(12):990-998.
Novaretti N, Cunha ALN, Bezerra TC, et al. The prevalence and correlation of non-motor symptoms in adult patients with idiopathic focal or segmental dystonia. Tremor Other Hyperkinet Mov (N Y) 2019;9:596.
Stamelou M, Edwards MJ, Hallett M, Bhatia KP. The non-motor syndrome of primary dystonia: clinical and pathophysiological implications. Brain 2012;135(Pt 6):1668-1681.
Camargo CH, Cattai L, Teive HA. Pain relief in cervical dystonia with botulinum toxin treatment. Toxins (Basel) 2015;7(6):2321-2335.
Kutvonen O, Dastidar P, Nurmikko T. Pain in spasmodic torticollis. Pain 1997;69(3):279-286.
Rosales RL, Cuffe L, Regnault B, Trosch RM. Pain in cervical dystonia: mechanisms, assessment and treatment. Expert Rev Neurother 2021;21(10):1125-1134.
Page D, Butler A, Jahanshahi M. Quality of life in focal, segmental, and generalized dystonia. Mov Disord 2007;22(3):341-347.
Mylius V, Perez Lloret S, Cury RG, et al. The Parkinson disease pain classification system: results from an international mechanism-based classification approach. Pain 2021;162(4):1201-1210.
Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform 2019;95:103208.
Furr RM. Scale Construction and Psychometrics for Social and Personality Psychology. London: SAGE; 2011.
Chaudhuri KR, Martinez-Martin P, Brown RG, et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov Disord 2007;22(13):1901-1911.
Chaudhuri KR, Rizos A, Trenkwalder C, et al. King's Parkinson's disease pain scale, the first scale for pain in PD: an international validation. Mov Disord 2015;30(12):1623-1631.
Ford B. Pain in Parkinson's disease. Mov Disord 2010;25(Suppl 1):S98-S103.
Wasner G, Deuschl G. Pains in Parkinson disease-many syndromes under one umbrella. Nat Rev Neurol 2012;8(5):284-294.
World Health Organization. International Classification of Diseases Eleventh Revision (ICD-11). Geneva: World Health Organization; 2022.
Health USDo, Human Services FDACfDE, Research et al. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 2006;4:79.
Erickson P, Willke R, Burke L. A concept taxonomy and an instrument hierarchy: tools for establishing and evaluating the conceptual framework of a patient-reported outcome (PRO) instrument as applied to product labeling claims. Value Health 2009;12(8):1158-1167.
Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 1985;35(1):73-77.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67(6):361-370.
Botega NJ, Bio MR, Zomignani MA, Garcia C Jr, Pereira WA. Mood disorders among inpatients in ambulatory and validation of the anxiety and depression scale HAD. Rev Saude Publica 1995;29(5):355-363.
Menezes Rde M, Andrade MV, Noronha KV, Kind P. EQ-5D-3L as a health measure of Brazilian adult population. Qual Life Res 2015;24(11):2761-2776.
Ferreira KA, Teixeira MJ, Mendonza TR, Cleeland CS. Validation of brief pain inventory to Brazilian patients with pain. Support Care Cancer 2011;19(4):505-511.
Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore 1994;23(2):129-138.
Santos JG, Brito JO, de Andrade DC, et al. Translation to Portuguese and validation of the Douleur Neuropathique 4 questionnaire. J Pain 2010;11(5):484-490.
Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005;114(1-2):29-36.
Freynhagen R, Parada HA, Calderon-Ospina CA, et al. Current understanding of the mixed pain concept: a brief narrative review. Curr Med Res Opin 2019;35(6):1011-1018.
Rodrigues FB, Duarte GS, Marques RE, et al. Botulinum toxin type a therapy for cervical dystonia. Cochrane Database Syst Rev 2020;11:CD003633.
Junker J, Berman BD, Hall J, et al. Quality of life in isolated dystonia: non-motor manifestations matter. J Neurol Neurosurg Psychiatry 2021;92:622-628.
Mylius V, Brebbermann J, Dohmann H, Engau I, Oertel WH, Moller JC. Pain sensitivity and clinical progression in Parkinson's disease. Mov Disord 2011;26(12):2220-2225.
Consky ES, Basinki A, Belle L, Ranawaya R, Lang AE. The Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS): assessment of validity and inter-rater reliability. Neurology 1990;40:445.
Klingelhoefer L, Chaudhuri KR, Kamm C, et al. Validation of a self-completed dystonia non-motor symptoms questionnaire. Ann Clin Transl Neurol 2019;6(10):2054-2065.
Protopapas MG, Bundock E, Westmoreland S, Nero C, Graham WA, Nesathurai S. The complications of scar formation associated with intrathecal pump placement. Arch Phys Med Rehabil 2007;88(3):389-390.
Bezerra ME, Rocha-Filho PA. Headache attributed to Craniocervical dystonia-a little known headache. Headache 2017;57(2):336-343.
Cury RG, Galhardoni R, Fonoff ET, et al. Effects of deep brain stimulation on pain and other nonmotor symptoms in Parkinson disease. Neurology 2014;83(16):1403-1409.
Listik C, Cury RG, Casagrande SCB, et al. Improvement of non-motor symptoms and quality of life after deep brain stimulation for refractory dystonia: a 1-year follow-up. Front Neurol 2021;12:717239.
Erro R, Rocchi L, Antelmi E, et al. High frequency somatosensory stimulation in dystonia: evidence for defective inhibitory plasticity. Mov Disord 2018;33(12):1902-1909.
Antelmi E, Erro R, Rocchi L, et al. Neurophysiological correlates of abnormal somatosensory temporal discrimination in dystonia. Mov Disord 2017;32(1):141-148.
Tinazzi M, Squintani GM, Bhatia KP, et al. Pain in cervical dystonia: evidence of abnormal inhibitory control. Parkinsonism Relat Disord 2019;65:252-255.
Erro R, Antelmi E, Bhatia KP, et al. Reversal of temporal discrimination in cervical dystonia after low-frequency sensory stimulation. Mov Disord 2021;36(3):761-766.
Conte A, Belvisi D, De Bartolo MI, et al. Abnormal sensory gating in patients with different types of focal dystonias. Mov Disord 2018;33(12):1910-1917.
Sadnicka A, Kimmich O, Pisarek C, et al. Pallidal stimulation for cervical dystonia does not correct abnormal temporal discrimination. Mov Disord 2013;28(13):1874-1877.
Manzo N, Ginatempo F, Belvisi D, et al. Pathophysiological mechanisms of oromandibular dystonia. Clin Neurophysiol 2022;134:73-80.
Lehericy S, Tijssen MA, Vidailhet M, Kaji R, Meunier S. The anatomical basis of dystonia: current view using neuroimaging. Mov Disord 2013;28(7):944-957.
Bologna M, Berardelli A. The cerebellum and dystonia. Handb Clin Neurol 2018;155:259-272.
Borsook D, Upadhyay J, Chudler EH, Becerra L. A key role of the basal ganglia in pain and analgesia-insights gained through human functional imaging. Mol Pain 2010;6:27.
Lobbezoo F, Tanguay R, Thon MT, Lavigne GJ. Pain perception in idiopathic cervical dystonia (spasmodic torticollis). Pain 1996;67(2-3):483-491.
Paracka L, Wegner F, Blahak C, et al. Sensory alterations in patients with isolated idiopathic dystonia: an exploratory quantitative sensory testing analysis. Front Neurol 2017;8:553.
Suttrup I, Oberdiek D, Suttrup J, Osada N, Evers S, Marziniak M. Loss of sensory function in patients with idiopathic hand dystonia. Mov Disord 2011;26(1):107-113.
Listik C, Cury RG, da Silva VA, et al. Abnormal sensory thresholds of dystonic patients are not affected by deep brain stimulation. Eur J Pain 2021;25(6):1355-1366.
Bradley D, Whelan R, Walsh R, et al. Temporal discrimination threshold: VBM evidence for an endophenotype in adult onset primary torsion dystonia. Brain 2009;132(9):2327-2335.
Abbruzzese G, Berardelli A. Sensorimotor integration in movement disorders. Mov Disord 2003;18(3):231-240.
Tinazzi M, Valeriani M, Squintani G, et al. Nociceptive pathway function is normal in cervical dystonia: a study using laser-evoked potentials. J Neurol 2012;259(10):2060-2066.
Valldeoriola F, Regidor I, Minguez-Castellanos A, et al. Efficacy and safety of pallidal stimulation in primary dystonia: results of the Spanish multicentric study. J Neurol Neurosurg Psychiatry 2010;81(1):65-69.
Mueller J, Skogseid IM, Benecke R, et al. Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: results from a prospective, randomized sham-controlled trial. Mov Disord 2008;23(1):131-134.
Sa KN, Moreira L, Baptista AF, et al. Prevalence of chronic pain in developing countries: systematic review and meta-analysis. Pain Rep 2019;4(6):e779.
Moisset X, Ouchchane L, Guy N, Bayle DJ, Dallel R, Clavelou P. Migraine headaches and pain with neuropathic characteristics: comorbid conditions in patients with multiple sclerosis. Pain 2013;154(12):2691-2699.
Barbosa LM, da Silva VA, de Lima Rodrigues AL, et al. Dissecting central post-stroke pain: a controlled symptom-psychophysical characterization. Brain Commun 2022;4(3):fcac090.
Listik C. Efeitos da estimulação cerebral profunda nos limiares sensitivos e de dor em pacientes distônicos. [Dissertação]. São Paulo: Universidade de São Paulo, Faculdade de Medicina; 2020.
Treede RD, Rief W, Barke A, et al. Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the international classification of diseases (ICD-11). Pain 2019;160(1):19-27.
Nicholas M, Vlaeyen JWS, Rief W, et al. The IASP classification of chronic pain for ICD-11: chronic primary pain. Pain 2019;160(1):28-37.
Nugraha B, Gutenbrunner C, Barke A, et al. The IASP classification of chronic pain for ICD-11: functioning properties of chronic pain. Pain 2019;160(1):88-94.
Klingelhoefer L, Kaiser M, Sauerbier A, et al. Emotional well-being and pain could be a greater determinant of quality of life compared to motor severity in cervical dystonia. J Neural Transm (Vienna) 2021;128(3):305-314.
Services USDoHaH, (FDA) FaDA, (CDER) CfDEaR, (CBER) CfBEaR, (CDRH) CfDaRH. Guidance for industry-patient-reported outcome measures: use in medical product development to support labeling claims 2009;1-39.